These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20189371)

  • 1. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer.
    Healy LA; Ryan AM; Carroll P; Ennis D; Crowley V; Boyle T; Kennedy MJ; Connolly E; Reynolds JV
    Clin Oncol (R Coll Radiol); 2010 May; 22(4):281-8. PubMed ID: 20189371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study.
    Brochu M; Mathieu ME; Karelis AD; Doucet E; Lavoie ME; Garrel D; Rabasa-Lhoret R
    Obesity (Silver Spring); 2008 May; 16(5):1085-93. PubMed ID: 18356851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome.
    Santos AC; Lopes C; Guimarães JT; Barros H
    Int J Obes (Lond); 2005 Dec; 29(12):1452-6. PubMed ID: 16077717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation in insulin sensitivity with increasing severity of the metabolic syndrome in obese postmenopausal women.
    Karelis AD; Henry JF; St-Pierre DH; Prud'homme D; Rabasa-Lhoret R
    Diabetes Obes Metab; 2006 May; 8(3):336-41. PubMed ID: 16634994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHBG levels correlate with insulin resistance in postmenopausal women.
    Akin F; Bastemir M; Alkiş E; Kaptanoglu B
    Eur J Intern Med; 2009 Mar; 20(2):162-7. PubMed ID: 19327605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
    Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
    J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women.
    Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R
    Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin.
    González AS; Guerrero DB; Soto MB; Díaz SP; Martinez-Olmos M; Vidal O
    Eur J Clin Nutr; 2006 Jun; 60(6):802-9. PubMed ID: 16493453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of metabolic syndrome with triple-negative breast cancer.
    Maiti B; Kundranda MN; Spiro TP; Daw HA
    Breast Cancer Res Treat; 2010 Jun; 121(2):479-83. PubMed ID: 19851862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein is elevated in obese patients with the metabolic syndrome.
    Florez H; Castillo-Florez S; Mendez A; Casanova-Romero P; Larreal-Urdaneta C; Lee D; Goldberg R
    Diabetes Res Clin Pract; 2006 Jan; 71(1):92-100. PubMed ID: 16002176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between several insulin sensitivity indices and metabolic risk factors in overweight and obese postmenopausal women: a MONET study.
    Malita FM; Messier V; Lavoie JM; Bastard JP; Rabasa-Lhoret R; Karelis AD
    Nutr Metab Cardiovasc Dis; 2010 Mar; 20(3):173-9. PubMed ID: 19501492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial.
    Frank LL; Sorensen BE; Yasui Y; Tworoger SS; Schwartz RS; Ulrich CM; Irwin ML; Rudolph RE; Rajan KB; Stanczyk F; Bowen D; Weigle DS; Potter JD; McTiernan A
    Obes Res; 2005 Mar; 13(3):615-25. PubMed ID: 15833948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women.
    Faria AN; Ribeiro Filho FF; Gouveia Ferreira SR; Zanella MT
    Obes Res; 2002 Dec; 10(12):1203-6. PubMed ID: 12490663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor analysis of metabolic syndrome components in obese women.
    Lafortuna CL; Adorni F; Agosti F; Sartorio A
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):233-41. PubMed ID: 17600693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
    Vona-Davis L; Howard-McNatt M; Rose DP
    Obes Rev; 2007 Sep; 8(5):395-408. PubMed ID: 17716297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vitamin D receptor gene BsmI polymorphism is not associated with anthropometric and biochemical parameters describing metabolic syndrome in postmenopausal women.
    Tworowska-Bardzińska U; Lwow F; Kubicka E; Łaczmański Ł; Jedzrzejuk D; Dunajska K; Milewicz A
    Gynecol Endocrinol; 2008 Sep; 24(9):514-8. PubMed ID: 18958772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women.
    Gaspard U
    Maturitas; 2009 Apr; 62(4):362-5. PubMed ID: 19131194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.